Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Palella, R. Baker, A. Moorman, J. Chmiel, K. Wood, J. Brooks, S. Holmberg (2006)
Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 43
Palella (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.N Engl J Med, 338
R. Yarchoan, T. Uldrick (2018)
HIV‐Associated Cancers and Related DiseasesThe New England Journal of Medicine, 378
B. McCullar, Taylor Alloway, Mike Martin (2017)
Durable complete response to nivolumab in a patient with HIV and metastatic non-small cell lung cancer.Journal of thoracic disease, 9 6
J. Larkin, V. Chiarion-Sileni, R. Gonzalez, J. Grob, C. Cowey, C. Lao, D. Schadendorf, R. Dummer, M. Smylie, P. Rutkowski, P. Ferrucci, A. Hill, J. Wagstaff, M. Carlino, J. Haanen, M. Maio, I. Márquez-Rodas, G. McArthur, P. Ascierto, G. Long, M. Callahan, M. Postow, M. Postow, K. Grossmann, M. Sznol, B. Dréno, L. Bastholt, A. Yang, L. Rollin, C. Horak, F. Hodi, J. Wolchok, J. Wolchok (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.The New England journal of medicine, 373 1
H. Torres, V. Mulanovich (2014)
Management of HIV infection in patients with cancer receiving chemotherapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 59 1
Jeffrey Jones, D. Hanson, M. Dworkin, D. Alderton, P. Fleming, J. Kaplan, J. Ward (1999)
Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries, 48 2
R. Herbst, P. Baas, Dong-Wan Kim, E. Felip, J. Pérez-Gracia, Ji-Youn Han, J. Molina, Joo‐Hang Kim, C. Arvis, M. Ahn, M. Majem, M. Fidler, G. Castro, M. Garrido, G. Lubiniecki, Shentu Yue, E. Im, M. Dolled-Filhart, E. Garon (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trialThe Lancet, 387
M. Hentrich, K. Schipek-Voigt, H. Jäger, S. Schulz, Peter Schmid, O. Stötzer, P. Bojko (2017)
Nivolumab in HIV-related non-small-cell lung cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 28 11
S. Park, A. Sacco, E. Cohen, G. Daniels (2018)
Safety and efficacy of checkpoint inhibition (CI) in cancer patients (pts) with concurrent human immunodeficiency virus (HIV) infection.Journal of Clinical Oncology, 36
K. Scilla, D. Zandberg, S. Bentzen, C. Mainor, J. Heath, O. Ioffe, Ashley Cellini, M. Edelman, D. Riedel, J. Feliciano (2018)
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection.Lung cancer, 123
M. González-Cao, J. Martinez-Picado, M. Pulla, B. Clotet, Ó. Juan, J. Dalmau, T. Moran, A. Mayerhans, J. Castro, J. Blanco, R. Blanco, R. Caro, N. Karachaliou, J. Garcia-Corbacho, M. Molina, C. Brander, R. Rosell (2017)
1208TiPA phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumorsAnnals of Oncology, 28
N. Mounier, C. Katlama, D. Costagliola, R. Chichmanian, J. Spano (2009)
Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.Critical reviews in oncology/hematology, 72 1
T. Uldrick, G. Ison, M. Rudek, A. Noy, K. Schwartz, S. Bruinooge, Caroline Schenkel, Barry Miller, K. Dunleavy, Judy Wang, J. Zeldis, R. Little (2017)
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 33
Lorena Ostios-Garcia, J. Faig, G. Leonardi, A. Adeni, S. Subegdjo, C. Lydon, Deepa Rangachari, M. Huberman, K. Sehgal, M. Shea, P. VanderLaan, M. Cheng, F. Marty, S. Hammond, D. Costa, M. Awad (2018)
Safety and Efficacy of PD‐1 Inhibitors Among HIV‐Positive Patients With Non–Small Cell Lung CancerJournal of Thoracic Oncology, 13
M. Burke, H. Kluger, M. Golden, K. Heller, A. Hoos, M. Sznol (2011)
Case Report: response to ipilimumab in a patient with HIV with metastatic melanoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 32
F. Palella, K. Delaney, A. Moorman, M. Loveless, J. Fuhrer, G. Satten, D. Aschman, S. Holmberg (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.The New England journal of medicine, 338 13
G. Garff, A. Samri, S. Lambert-Niclot, S. Even, A. Lavolé, J. Cadranel, J. Spano, B. Autran, A. Marcelin, A. Guihot (2017)
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.AIDS, 31 7
J. Ruzevick, S. Nicholas, K. Redmond, L. Kleinberg, E. Lipson, M. Lim (2013)
A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the BrainCase Reports in Oncological Medicine, 2013
D. Davar, M. Wilson, Chelsea Pruckner, J. Kirkwood (2015)
PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIVCase Reports in Oncological Medicine, 2015
M. Hellmann, T. Ciuleanu, A. Płużański, J. Lee, G. Otterson, C. Audigier-Valette, E. Minenza, H. Linardou, S. Burgers, P. Salman, H. Borghaei, S. Ramalingam, J. Brahmer, M. Reck, K. O'Byrne, W. Geese, G. Green, Han-Cheng Chang, J. Szustakowski, P. Bhagavatheeswaran, D. Healey, Yali Fu, F. Nathan, L. Paz-Ares (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational BurdenThe New England Journal of Medicine, 378
M. Heppt, M. Schlaak, T. Eigentler, K. Kähler, F. Kiecker, C. Loquai, F. Meier, D. Tomsitz, N. Brenner, A. Niesert, R. Thonke, A. Hauschild, C. Berking (2017)
Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients.Annals of oncology : official journal of the European Society for Medical Oncology, 28 12
E. Yanik, Genevieve Kaunitz, T. Cottrell, F. Succaria, T. McMiller, M. Ascierto, Jessica Esandrio, Haiying Xu, A. Ogurtsova, Toby Cornish, E. Lipson, S. Topalian, E. Engels, J. Taube (2017)
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for ImmunotherapyJAMA Oncology, 3
J. Wolchok, H. Kluger, M. Callahan, M. Postow, N. Rizvi, A. Lesokhin, N. Segal, C. Ariyan, R. Gordon, Kathleen Reed, M. Burke, A. Caldwell, S. Kronenberg, B. Agunwamba, Xiaoling Zhang, I. Lowy, H. Inzunza, W. Feely, C. Horak, Q. Hong, A. Korman, J. Wigginton, A. Gupta, M. Sznol (2013)
Nivolumab plus ipilimumab in advanced melanoma.The New England journal of medicine, 369 2
K. Grabmeier-Pfistershammer, P. Steinberger, A. Rieger, J. Leitner, N. Kohrgruber (2011)
Identification of PD-1 as a Unique Marker for Failing Immune Reconstitution in HIV-1–Infected Patients on TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 56
D. Tomsitz, R. Hein, T. Biedermann, J. Kohlmeyer (2018)
Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumabJournal of the European Academy of Dermatology and Venereology, 32
R. Rai, Ogochukwu Ezeoke, J. McQuade, L. Zimmer, C. Koo, John Park, L. Ardolino, D. Yip, S. Goldinger, J. Cohen, M. Millward, V. Atkinson, A. Kane, P. Ascierto, C. Garbe, R. Gutzmer, Douglas Johnson, M. Hellman, G. Long, A. Menzies (2017)
Immunotherapy in patients with concurrent solid organ transplant, HIV, and Hepatitis B and CAnnals of Oncology, 28
N. Galanina, A. Goodman, Philip Cohen, R. Kurzrock (2018)
HIV-positive Kaposi sarcoma and immune checkpoint blockade.Journal of Clinical Oncology, 36
M. Reck, D. Rodríguez-Abreu, A. Robinson, R. Hui, T. Csőszi, A. Fülöp, M. Gottfried, N. Peled, A. Tafreshi, S. Cuffe, M. O'Brien, Suman Rao, K. Hotta, M. Leiby, G. Lubiniecki, Shentu Yue, Reshma Rangwala, J. Brahmer (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.The New England journal of medicine, 375 19
A. Makinson, J. Pujol, V. Moing, H. Peyrière, J. Reynes (2010)
Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 5 4
L. Rajdev, E. Chiao, S. Lensing, H. Streicher, R. Little, D. Dittmer, M. Einstein, M. Haigentz, J. Sparano, R. Mitsuyasu (2018)
AIDS malignancy consortium (AMC) 095: A phase I study of ipilimumab (IPI) and nivolumab (NIVO) in advanced HIV-associated solid tumors (ST) with expansion cohorts in HIV-associated solid tumors and classical Hodgkin lymphoma (cHL).Journal of Clinical Oncology, 36
A. Guihot, A. Guihot, A. Marcelin, A. Marcelin, M. Massiani, A. Samri, C. Soulié, B. Autran, B. Autran, Jean-Philippe Spano, Jean-Philippe Spano (2018)
Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 29 2
V. Velu, R. Shetty, M. Larsson, E. Shankar (2015)
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic optionsRetrovirology, 12
Elaine Chang, G. Rivero, N. Patel, E. Chiao, S. Lai, Kelash Bajaj, John Mbue, S. Yellapragada (2018)
HIV‐related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to NivolumabClinical Lymphoma, Myeloma & Leukemia, 18
J. Sandoval-Sus, F. Mogollon-Duffo, Ankita Patel, N. Visweshwar, D. Laber, R. Kim, Michael Jagal (2017)
Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathyJournal for Immunotherapy of Cancer, 5
Vanessa Evans, Renée Sluis, A. Solomon, A. Dantanarayana, C. McNeil, R. Garsia, S. Palmer, R. Fromentin, N. Chomont, R. Sékaly, P. Cameron, S. Lewin (2018)
Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latencyAIDS, 32
F. Wightman, A. Solomon, Sanjeev Kumar, Nicolás Urriola, Kerri Gallagher, B. Hiener, S. Palmer, C. McNeil, R. Garsia, S. Lewin (2015)
Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma.AIDS, 29 4
H. Borghaei, L. Paz-Ares, L. Horn, D. Spigel, M. Steins, N. Ready, L. Chow, E. Vokes, E. Felip, E. Holgado, F. Barlesi, M. Kohlhäufl, O. Arrieta, M. Burgio, J. Fayette, H. Léna, E. Poddubskaya, D. Gerber, S. Gettinger, C. Rudin, N. Rizvi, L. Crinò, G. Blumenschein, S. Antonia, C. Dorange, C. Harbison, F. Finckenstein, J. Brahmer (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.The New England journal of medicine, 373 17
F. Porichis, M. Hart, António Massa, Holly Everett, A. Morou, J. Richard, N. Brassard, M. Veillette, M. Hassan, Ngoc Ly, J. Routy, G. Freeman, M. Dubé, A. Finzi, D. Kaufmann (2018)
Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK CellsThe Journal of Immunology, 201
J. Brahmer, K. Reckamp, P. Baas, L. Crinò, W. Eberhardt, E. Poddubskaya, S. Antonia, A. Płużański, E. Vokes, E. Holgado, D. Waterhouse, N. Ready, J. Gainor, O. Frontera, L. Havel, M. Steins, M. Garassino, J. Aerts, M. Dómine, L. Paz-Ares, M. Reck, C. Baudelet, C. Harbison, B. Lestini, D. Spigel (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.The New England journal of medicine, 373 2
A. Ribas, J. Wolchok (2018)
Cancer immunotherapy using checkpoint blockadeScience, 359
This systematic review examines the association of immune checkpoint inhibitor therapy with immune-related adverse effects, antitumor activity, and viral load in patients with HIV infection and advanced-stage cancer.
JAMA Oncology – American Medical Association
Published: Jul 7, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.